The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...

The regulator cited deficiencies at a third-party manufacturing facility. Camurus is seeking approval for its ...

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

The FDA handed a CRL to the Swedish biotech Camurus for its hormone disorder therapy over “facility-related deficiencies” at ...

CAM2029 is a novel depot formulation of octreotide, a somatostatin analogue, administered subcutaneously once monthly.

In a summary of current health news: the CDC investigates bird flu in Washington, David Joyner becomes CVS CEO, China tackles ...

Schally, PhD-- who won a Nobel Prize for discovering the hormones used by the brain to control growth, reproduction, and ...

Munters Group AB posted the largest decline among large stocks during the session, plunging 11.0%, followed by Camurus AB shares, which declined 9.8%. Shares of Lifco AB Series B fell 5.8%.

Delhi HC closed contempt proceedings against Wikipedia after the platform globally removed a defamatory page. The court criticized Wikipedia for refusing to disclose user identities responsible ...

Phuket Smart Bus (PKSB) yesterday launched a new electric bus service connecting Phuket Town and Patong. The service is priced at just 50 baht per passenger. The launch yesterday, October 9, saw ...